Impediments to parallel trade in pharmaceuticals within the European Community: final report
Gespeichert in:
| Format: | Regierungsdokument Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Luxembourg
Office for Official Publ. of the Europ. Communities
1992
|
| Schriftenreihe: | Document / Commission of the European Communities
Deadline 92 |
| Schlagworte: | |
| Beschreibung: | 85 S. graph. Darst. |
| ISBN: | 9282636607 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV023520823 | ||
| 003 | DE-604 | ||
| 005 | 20080402000000.0 | ||
| 007 | t | ||
| 008 | 991012s1992 lu d||| ||||i00||| eng d | ||
| 020 | |a 9282636607 |9 92-826-3660-7 | ||
| 035 | |a (OCoLC)231433291 | ||
| 035 | |a (DE-599)BVBBV023520823 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 044 | |a lu |c XA-LU | ||
| 049 | |a DE-521 | ||
| 050 | 0 | |a HD9671.E92I46 1992 | |
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 086 | |a CM-73-91-489-EN-C | ||
| 245 | 1 | 0 | |a Impediments to parallel trade in pharmaceuticals within the European Community |b final report |c prepared for DGIV of the European Commission by REMIT Consultants, London |
| 264 | 1 | |a Luxembourg |b Office for Official Publ. of the Europ. Communities |c 1992 | |
| 300 | |a 85 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Document / Commission of the European Communities | |
| 490 | 0 | |a Deadline 92 | |
| 610 | 2 | 7 | |a Europäische Gemeinschaften |0 (DE-588)35439-9 |2 gnd |9 rswk-swf |
| 650 | 4 | |a Pharmaceutical industry -- European Economic Community countries | |
| 650 | 0 | 7 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelhandel |0 (DE-588)4143178-9 |2 gnd |9 rswk-swf |
| 651 | 4 | |a Europäische Gemeinschaften. Mitgliedsstaaten | |
| 651 | 7 | |a Großbritannien |0 (DE-588)4022153-2 |2 gnd |9 rswk-swf | |
| 651 | 7 | |a Deutschland |0 (DE-588)4011882-4 |2 gnd |9 rswk-swf | |
| 651 | 7 | |a Niederlande |0 (DE-588)4042203-3 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a Europäische Gemeinschaften |0 (DE-588)35439-9 |D b |
| 689 | 0 | 1 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Deutschland |0 (DE-588)4011882-4 |D g |
| 689 | 1 | 1 | |a Arzneimittelhandel |0 (DE-588)4143178-9 |D s |
| 689 | 1 | 2 | |a Großbritannien |0 (DE-588)4022153-2 |D g |
| 689 | 1 | 3 | |a Niederlande |0 (DE-588)4042203-3 |D g |
| 689 | 1 | |8 1\p |5 DE-604 | |
| 710 | 2 | |a Europäische Kommission |e Sonstige |0 (DE-588)1024466-9 |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016841124 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804138161457070080 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| building | Verbundindex |
| bvnumber | BV023520823 |
| callnumber-first | H - Social Science |
| callnumber-label | HD9671 |
| callnumber-raw | HD9671.E92I46 1992 |
| callnumber-search | HD9671.E92I46 1992 |
| callnumber-sort | HD 49671 E92 I46 41992 |
| callnumber-subject | HD - Industries, Land Use, Labor |
| classification_rvk | QR 525 |
| ctrlnum | (OCoLC)231433291 (DE-599)BVBBV023520823 |
| discipline | Wirtschaftswissenschaften |
| discipline_str_mv | Wirtschaftswissenschaften |
| format | Government Document Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02123nam a2200529zc 4500</leader><controlfield tag="001">BV023520823</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20080402000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">991012s1992 lu d||| ||||i00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9282636607</subfield><subfield code="9">92-826-3660-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)231433291</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023520823</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">lu</subfield><subfield code="c">XA-LU</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-521</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9671.E92I46 1992</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="086" ind1=" " ind2=" "><subfield code="a">CM-73-91-489-EN-C</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Impediments to parallel trade in pharmaceuticals within the European Community</subfield><subfield code="b">final report</subfield><subfield code="c">prepared for DGIV of the European Commission by REMIT Consultants, London</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Luxembourg</subfield><subfield code="b">Office for Official Publ. of the Europ. Communities</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">85 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Document / Commission of the European Communities</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Deadline 92</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Europäische Gemeinschaften</subfield><subfield code="0">(DE-588)35439-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry -- European Economic Community countries</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelhandel</subfield><subfield code="0">(DE-588)4143178-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">Europäische Gemeinschaften. Mitgliedsstaaten</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Niederlande</subfield><subfield code="0">(DE-588)4042203-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Europäische Gemeinschaften</subfield><subfield code="0">(DE-588)35439-9</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelhandel</subfield><subfield code="0">(DE-588)4143178-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Niederlande</subfield><subfield code="0">(DE-588)4042203-3</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Europäische Kommission</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1024466-9</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016841124</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| geographic | Europäische Gemeinschaften. Mitgliedsstaaten Großbritannien (DE-588)4022153-2 gnd Deutschland (DE-588)4011882-4 gnd Niederlande (DE-588)4042203-3 gnd |
| geographic_facet | Europäische Gemeinschaften. Mitgliedsstaaten Großbritannien Deutschland Niederlande |
| id | DE-604.BV023520823 |
| illustrated | Illustrated |
| index_date | 2024-07-02T22:32:50Z |
| indexdate | 2024-07-09T21:23:47Z |
| institution | BVB |
| institution_GND | (DE-588)1024466-9 |
| isbn | 9282636607 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016841124 |
| oclc_num | 231433291 |
| open_access_boolean | |
| owner | DE-521 |
| owner_facet | DE-521 |
| physical | 85 S. graph. Darst. |
| publishDate | 1992 |
| publishDateSearch | 1992 |
| publishDateSort | 1992 |
| publisher | Office for Official Publ. of the Europ. Communities |
| record_format | marc |
| series2 | Document / Commission of the European Communities Deadline 92 |
| spelling | Impediments to parallel trade in pharmaceuticals within the European Community final report prepared for DGIV of the European Commission by REMIT Consultants, London Luxembourg Office for Official Publ. of the Europ. Communities 1992 85 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Document / Commission of the European Communities Deadline 92 Europäische Gemeinschaften (DE-588)35439-9 gnd rswk-swf Pharmaceutical industry -- European Economic Community countries Arzneimittelmarkt (DE-588)4003131-7 gnd rswk-swf Arzneimittelhandel (DE-588)4143178-9 gnd rswk-swf Europäische Gemeinschaften. Mitgliedsstaaten Großbritannien (DE-588)4022153-2 gnd rswk-swf Deutschland (DE-588)4011882-4 gnd rswk-swf Niederlande (DE-588)4042203-3 gnd rswk-swf Europäische Gemeinschaften (DE-588)35439-9 b Arzneimittelmarkt (DE-588)4003131-7 s DE-604 Deutschland (DE-588)4011882-4 g Arzneimittelhandel (DE-588)4143178-9 s Großbritannien (DE-588)4022153-2 g Niederlande (DE-588)4042203-3 g 1\p DE-604 Europäische Kommission Sonstige (DE-588)1024466-9 oth 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Impediments to parallel trade in pharmaceuticals within the European Community final report Europäische Gemeinschaften (DE-588)35439-9 gnd Pharmaceutical industry -- European Economic Community countries Arzneimittelmarkt (DE-588)4003131-7 gnd Arzneimittelhandel (DE-588)4143178-9 gnd |
| subject_GND | (DE-588)35439-9 (DE-588)4003131-7 (DE-588)4143178-9 (DE-588)4022153-2 (DE-588)4011882-4 (DE-588)4042203-3 |
| title | Impediments to parallel trade in pharmaceuticals within the European Community final report |
| title_auth | Impediments to parallel trade in pharmaceuticals within the European Community final report |
| title_exact_search | Impediments to parallel trade in pharmaceuticals within the European Community final report |
| title_exact_search_txtP | Impediments to parallel trade in pharmaceuticals within the European Community final report |
| title_full | Impediments to parallel trade in pharmaceuticals within the European Community final report prepared for DGIV of the European Commission by REMIT Consultants, London |
| title_fullStr | Impediments to parallel trade in pharmaceuticals within the European Community final report prepared for DGIV of the European Commission by REMIT Consultants, London |
| title_full_unstemmed | Impediments to parallel trade in pharmaceuticals within the European Community final report prepared for DGIV of the European Commission by REMIT Consultants, London |
| title_short | Impediments to parallel trade in pharmaceuticals within the European Community |
| title_sort | impediments to parallel trade in pharmaceuticals within the european community final report |
| title_sub | final report |
| topic | Europäische Gemeinschaften (DE-588)35439-9 gnd Pharmaceutical industry -- European Economic Community countries Arzneimittelmarkt (DE-588)4003131-7 gnd Arzneimittelhandel (DE-588)4143178-9 gnd |
| topic_facet | Europäische Gemeinschaften Pharmaceutical industry -- European Economic Community countries Arzneimittelmarkt Arzneimittelhandel Europäische Gemeinschaften. Mitgliedsstaaten Großbritannien Deutschland Niederlande |
| work_keys_str_mv | AT europaischekommission impedimentstoparalleltradeinpharmaceuticalswithintheeuropeancommunityfinalreport |